Home » Archive

Drug Discovery

Drug Discovery, News, Syndication, Xconomy »

With Record $275M Gift, Sanford-Burnham Unveils New 10-Year Plan

Posted by sandiegobiotech January 28th, 2014 .
No Comments

San Diego’s Sanford-Burnham Medical Research Institute says today it has landed a $275 million pledge from an anonymous donor, just as the institute is embarking on a new 10-year strategic plan. The…

[[Click headline to continue reading.]]

More...

Drug Discovery, News, Syndication, Xconomy »

Using Bioprinting Technology, San Diego’s Organovo Makes 3D Tissue

Posted by sandiegobiotech April 23rd, 2013 .
No Comments

Organovo, a San Diego regenerative medicine company developing bio-printing technology, says it has used its proprietary NovaGen bioprinter to produce 3D samples of human liver cells that show some…

[[Click headline to continue reading.]]

More...

Drug Discovery, News, Syndication, Xconomy »

Xconomist of the Week: Alexis Borisy Still Likes Early Stage Biotechs

Posted by sandiegobiotech December 20th, 2012 .
No Comments

The trending topic among biotech people and the people who fund them these days is that it is almost impossible to scrounge up financing for startups in the earliest stages of drug development. As…

[[Click headline to continue reading.]]

More...

Drug Discovery, Events, Headline, SDBN Blog, SDBN Events »

SDBN August 21st 2012 Event At The Sanford Consortium For Regenerative Medicine

Posted by Mary Canady August 3rd, 2012 .
No Comments

The Sanford Consortium for Regenerative Medicine is a stem cell research facility representing a collaboration between five of San Diego’s finest research institutions: Sanford-Burnham Medical Research Institute, The Salk Institute, The Scripps Research Institute and the University of California, San Diego, and the La Jolla Institute for Allergy and Immunology. This new “collaboratory” opened in November of 2011, ideally located between the institutions in La Jolla, and demonstrates the power and potential of working together to fight disease. At our SDBN event August 21st, Evan Snyder, M.D., Ph.D., director of …

More...

Drug Development, Drug Discovery, News, Syndication, Xconomy »

Xconomist of the Week: John Reed on Sanford-Burnham’s Drug Pipeline

Posted by sandiegobiotech August 3rd, 2012 .
No Comments

In the decade since John Reed stepped in as chief executive, San Diego’s Sanford-Burnham Medical Research Institute has basically doubled in size. The nonprofit research facility has added a campus…

[[Click headline to continue reading.]]

More...

Drug Discovery, Headline »

SDBN June 25th Event With Lilly: Open Innovation Drug Discovery

Posted by Mary Canady June 4th, 2012 .
No Comments

San Diego biotech has grown thanks to a collaborative spirit which is sometimes manifested in the acquisition and joining of companies towards a common goal. Lilly’s presence here is indicative of this type of growth, beginning with their acquisition of SGX Pharmaceuticals and Applied Molecular Evolution, and they’ve continued to move forward and contribute to the region.

The SDBN is dedicated to helping the local life science community understand and leverage the fantastic opportunities available through networking and sharing resources. Lilly is a leader in this area and formed the Open …

More...

Diagnostics, Drug Development, Drug Discovery, Featured, SDBN Blog »

San Diego’s Biotechnology Companies: Who’s Taking Off?

Posted by Lara March 8th, 2012 .
No Comments

Here at SDBN we’ve been updating our directory of 400+ San Diego biotech companies.  We were surprised to find close to 40 companies removed from the local scene – due to acquisition or shut down.  But we also found a net gain in companies, with 68 added. We’ve begun to add some of the ‘provenances’ of new companies, as well as what’s happened to those that are no longer listed, and welcome your comments and additions as well, please leave them as a comment below. Note that some companies …

More...

Drug Development, Drug Discovery, Headline, SDBN Blog, SDBN Events »

SDBN March 26th 2012 Event with Organovo

Posted by Mary Canady March 6th, 2012 .
No Comments

Organovo is an exciting San Diego biotech company with technology to create human tissue through a technique called 3D bioprinting. The tissue can be used for drug discovery and development, and the company has been included in the MIT Technology Review’s 2012 TR50 list of the world’s most innovative companies. The excitement around Organovo has grown since they recently announced funding and their stock is now publicly traded. You’ll get the chance to hear from CEO Keith Murphy at our March 26th event, he’ll give a presentation titled ‘3D Bioprinting …

More...

Biotechnology, Conferences, Drug Discovery, Featured, SDBN Blog »

Focus on San Diego: Life Science Conferences Spring 2012

Posted by Mary Canady January 31st, 2012 .
No Comments

This spring San Diego downtown will be buzzing with scientific discussions as our city hosts a number of major scientific symposia.  We are excited to attend and soak in all the science that will be shared during these two months.  Our own Mary Canady will also be participating in a panel discussing on the triumphs and trials of Transitioning from Academia to Industry at the Annual meeting of the Biophysical Society on Tuesday, February 28, 2:30 PM – 4:00 PM.
We hope that you are planning on attending at least some …

More...

Drug Development, Drug Discovery, News, Syndication, Xconomy »

A Sweet Deal: How Amira Reinvented Itself as a Drug Discovery Engine

Posted by sandiegobiotech December 23rd, 2011 .
No Comments

The sale of Amira Pharmaceuticals will likely go down as one of the standout life sciences deals of 2011—it certainly ranks as one of the biggest payouts in San Diego, where Amira was founded in…

[[Click headline to continue reading.]]

More...